Transgenesis and neuroendocrine physiology: A transgenic rat model expressing growth hormone in vasopressin neurones

Journal of Physiology

Volumn 551, Issue 1, 2003, Pages 323-336

  Wells, Sara E ^a,c   Flavell, David M ^a,d   Bisset, Gordon W ^a   Houston, Pamela A ^a,e   Christian, Helen ^b   Fairhall, Keith M ^a   Robinson, Ian C A F ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HUMAN GROWTH HORMONE; MESSENGER RNA; NEUROPHYSIN; OXYTOCIN; VASOPRESSIN RECEPTOR; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE; VASOPRESSIN;

ADENOHYPOPHYSIS; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD SAMPLING; CELLULAR DISTRIBUTION; FEEDBACK SYSTEM; FEMALE; GENE CONSTRUCT; GENE EXPRESSION; GIANT CELL; GROWTH RATE; HABENULA; HORMONE RELEASE; HYPOTHALAMUS; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NEUROENDOCRINE SYSTEM; NEUROHYPOPHYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RADIOIMMUNOASSAY; RAT; REVIEW; STIMULUS RESPONSE; SUPRACHIASMATIC NUCLEUS; SUPRAOPTIC NUCLEUS; TRANSGENICS; ARTICLE; FLUID BALANCE; GROWTH HORMONE RELEASE; HORMONE TRANSPORT; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; JP17 TRANSGENIC RAT; JP59 TRANSGENIC RAT; MAGNOCELLULAR NUCLEUS; MEDIAL AMYGDALA; NERVE CELL; PARVOCELLULAR NEURON; PROTEIN EXPRESSION; RAT MODEL; TRANSGENE; TRANSGENIC RAT; VASOPRESSIN NEURON; VASOPRESSIN RELEASE;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIOLOGICAL ASSAY; BRAIN; CATTLE; FEMALE; GENE EXPRESSION; GROWTH; HUMAN GROWTH HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, IMMUNOELECTRON; NEURONS; NEUROPHYSINS; NITROSO COMPOUNDS; OXYTOCIN; PITUITARY GLAND; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; SODIUM CHLORIDE; TISSUE DISTRIBUTION; TRANSGENES; VASOPRESSINS;

EID: 0042780278     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2002.037655     Document Type: Review

References (70)

1. Ang H-L, Carter D & Murphy D (1993). Neuron-specific expression and physiological regulation of bovine vasopressin transgenes in transgenic mice. EMBO J 12, 2397-2409.
2. Arima H, House SB, Gainer H & Aguilera G (2002). Neuronal activity is required for the circadian rhythm of vasopressin gene transcription in the suprachiasmatic nucleus in vitro. Endocrinology 143, 4165-4171.
3. Ben-Barak Y, Russell JT, Whitnall MH, Ozato K & Gainer H (1985). Neurophysin in the hypothalamo-neurohypophysial system. I. Production and characterization of monoclonal antibodies. J Neurosci 5, 81-97.
4. Bennett PA, Levy A, Sophokleous S, Robinson ICAF & Lightman SL (1995). Hypothalamic GH receptor gene expression in the rat: effects of altered GH status. J Endocrinol 147, 225-234.
5. Bisset GW (1974). Milk ejection. In American Handbook of Physiology vol. IV, part 1 ed. Sawyer WH, pp. 493-520. Williams & Wilkins, Baltimore.
6. Bisset GW & Chowdrey HS (1984). A cholinergic link in the reflex release of vasopressin by hypotension in the rat. J Physiol 354, 523-545.
7. Bisset GW, Chowdrey HS, Fairhall KM & Gunn LK (1990). Central inhibition by gamma aminobutyric acid and muscimol of the release of vasopressin and oxytocin by an osmotic stimulus in the rat. Br J Pharmacol 99, 529-535.
8. Bisset GW & Fairhall KM (1996). Release of vasopressin and oxytocin by excitatory amino acid agonists and the effect of antagonists on release by muscarine and hypertonic saline, in the rat in vivo. Br J Pharmacol 117, 309-314.
9. Bisset GW, Fairhall KM & Tsuij K (1992). The effect of neosurugatoxin on the release of neurohypophysial hormones by nicotine, hypotension and an osmotic stimulus in the rat. Br J Pharmacol 106, 685-692.
10. Bonifer C, Vidal M, Grosveld F & Sippel AE (1990). Tissue-specific and position independent expression of the complete gene domain for chicken lysozyme in transgenic mice. EMBO J 9, 2843-2848.
11. Brown P, McNeily Jr, Wallace RM, McNeilly AS & Clark AJ (1993). Characterization of the ovine LH beta-subunit gene: the promoter directs gonadotrope-specific expression in transgenic mice. Mol Cell Endocrinol 93, 157-165.
12. Burbach J, Luckman SM, Murphy D & Gainer H (2001). Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol Rev 81, 1197-1267.
13. Burbach JP, Liu B, Voorhuis TAM & Van Tol HHM (1988). Diurnal variation on vasopressin and oxytocin messenger RNAs in hypothalamic nuclei of the rat. Mol Brain Res 4, 157-160.
14. Burnard DM, Pittman QJ & Veale WL (1984). Brattleboro rats display increased sensitivity to arginine vasopressin-induced motor disturbances. Brain Res 342, 316-322.
15. Caffé AR, Van Leeuwen FW & Luiten PGM (1987). Vasopressin cells in the medial amygdala of the rat project to the lateral septum and ventral hippocampus. J Comp Neurol 261, 237-252.
16. Chomczynski P & Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156-159.
17. Clark RG, Carlsson LMS & Robinson ICAF (1987). Growth hormone secretory profiles in conscious female rats. J Endocrinol 114, 399-407.
18. Clark RG, Chambers GR, Lewin JE & Robinson ICAF (1986). Automated repetitive microsampling of blood: growth hormone profiles in conscious male rats J Endocrinol 111, 27-35.
19. De Vries GJ & Buijs RM (1983). The origin of the vasopressinergic and oxytocinergic innervation of the rat brain with special reference to the lateral septum. Brain Res 273, 307-317.
20. de Wied D (1993). Central nervous system effects of neurohypophyseal hormones and related peptides. Front Neurosci 14, 251-302.
21. Dillon N & Grosveld F (1993). In Gene Transcription - A Practical Approach, ed. Hames BD & Higgins SJ, pp. 153-187. IRL Press at Oxford University Press, Oxford.
22. Flavell DM, Wells T, Wells SE, Carmignac DF, Thomas GB & Robinson ICAF (1996). Dominant dwarfism in transgenic rats by targeting human growth hormone (GH) expression to hypothalamic GH-releasing factor neurones. EMBO J 15, 3871-3879.
23. Foo NC, Carter D, Murphy D & Ivell R (1991). Vasopressin and oxytocin gene expression in rat testis. Endocrinology 128, 2118-2128.
24. Gainer H & Wray S (1994). Cellular and molecular biology of oxytocin and vasopressin. In The Physiology of Reproduction, 2nd edn, ed. Knobil E & Neill JD, pp. 1099-1129. Raven Press, New York.
25. Gillies GE, Linton EA & Lowry PJ (1982). Corticotrophin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299, 355-357.
26. Glasgow E, Kusano K, Chin H, Mezey E, Young Ws 3rd & Gainer H (1999). Single cell reverse transcription-polymerase chain reaction analysis of rat supraoptic magnocellular neurons: neuropeptide phenotypes and high voltage-gated calcium channel subtypes. Endocrinology 140, 5391-5401.
27. Grant FD, Reventos J, Gordon JW, Kawabata S, Miller M & Majzoub JA (1993). Expression of the rat arginine vasopressin gene in transgenic mice. Mol Endocrinol 7, 659-667.
28. Grosveld F, van Assendelft GB, Greaves DR & Kollias G (1987). Position-independent, high-level expression of human β-globin gene in transgenic mice. Cell 51, 975-985.
29. Ho M-Y, Carter DA, Ang H-L & Murphy D (1995). Bovine oxytocin transgenes in mice. J Biol Chem 270, 27199-27205.
30. Hogan B, Constantini F & Lacy E (1986). Manipulating the mouse embryo. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
31. Hollingshead PG, Martin L, Pitts SL & Stewart TA (1989). A dominant phenocopy of hypopituitarism in transgenic mice resulting from central nervous system synthesis of human growth hormone. Endocrinology 125, 1556-1564.
32. Jeong SW, Castel M, Zhang BJ, Fields RL, Paras P, Arnheiter H, Chin H & Gainer H (2001). Cell-specific expression and subcellular localization of neurophysin-CAT-fusion proteins expressed from oxytocin and vasopressin gene promoter-driven constructs in transgenic mice. Exp Neurol 171, 255-271.
33. Johansson D, Hilliges M, Olsson A & Östenson C-G, Morris M & Efendic S (199 1). Oxytocin in pancreatic islets-immunohistochemical localization in normal and non-insulin-dependent diabetic rats. Acta Physiol Scand 141, 143-144.
34. Kasting NW (1989). Criteria for establishing a physiological role for brain peptides. A case in point: the role of vasopressin in thermoregulation during fever and antipyresis. Brain Res Rev 14, 143-153.
35. Kineman RD, Aleppo G & Frohman LA (1996) The tyrosine hydroxylase-human growth hormone (GH) transgenic mouse as a model of hypothalamic GH deficiency: growth retardation is the result of a selective reduction in somatotrope numbers despite normal somatotrope function. Endocrinology 137, 4630-4636.
36. Kiyama H & Emson PC (1990). Evidence for the co-expression of oxytocin and vasopressin messenger ribonucleic acids in magnocellular neurosecretory cells: Simultaneous demonstration of two neurohypophysin messenger ribonucleic acids by hybridization histochemistry. J Neuroendocrinol 2, 257-259.
37. Laycock JF, Penn W, Shirley DG & Walter SJ (1979). The role of vasopressin in blood pressure regulation immediately following acute haemorrhage in the rat. J Physiol 296, 267-275.
38. Lightman SL & Young III WS (1987). Vasopressin, oxytocin, dynorphin, enkephalin and corticotrophin-releasing factor mRNA stimulation in the rat. J Physiol 394, 23-39.
39. Lolait SJ, O'Carroll A-M, McBride OW, Konig M, Morel A & Brownstein MJ (1992). Cloning and characterization of vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357, 336-340.
40. Magoulas C, McGuinness L, Balthasar N, Carmignac DF, Sesay AK, Mathers KE, Christian H, Candeil L, Bonnefont X, Mollard P & Robinson ICAF (2000). A secreted fluorescent reporter targeted to pituitary growth hormone cells in transgenic mice. Endocrinology 141, 4681-4689.
41. Mezey E & Kiss JZ (1991). Coexpression of vasopressin and oxytocin in hypothalamic supraoptic neurons of lactating rats. Endocrinology 129, 1814-1820.
42. Mohr E, Schmitz E & Richter D (1988). A single rat genomic DNA fragment encodes both the oxytocin and vasopressin genes separated by 11 kilobases and orientated in opposite transcriptional directions. Biochimie 70, 649-654.
43. Morris JF, Christian H, Ma D & Wang H (2000). Dendritic secretion of peptides from hypothalamic magnocellular neurosecretory neurones: a local dynamic control system and its functions. Exp Physiol 85, 131S-138S.
44. Murphy D & Wells SE (2003). In vivo gene transfer studies on the regulation and function of the magnocellular hypothalamo-neurohypophysial system. J Neuroendocrinol 15, 109-125.
45. Murphy D, Xu J & Waller S (2000). Transgenic studies in rats and mice on the osmotic regulation of vasopressin gene expression. Exp Physiol 85, 211S-222S.
46. Nussey SS, Ang VTY, Jenkins JS, Chowdrey HS & Bisset GW (1984). Brattleboro rat adrenal contains vasopressin. Nature 310, 64-66.
47. Pedersen CA, Ascher JA, Monroe YL & Prange Jr AJ (1982). Oxytocin induces maternal behaviour in virgin female rats. Science 216, 648-652.
48. Pellegrini E, Carmignac DF, Bluet-Pajot MT, Mounier F, Bennett P, Epelbaum J & Robinson ICAF (1997). Intrahypothalamic growth hormone feedback: from dwarfism to acromegaly in the rat. Endocrinology 138, 4543-4551.
49. Rivier C & Vale W (1983). Interaction of corticotrophin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113, 939-942.
50. Robinson ICAF (1980). The development and evaluation of a sensitive and specific radioimmunoassay for oxytocin in unextracted plasma. J Immunoassay 1, 323-347.
51. Robinson ICAF (1986). The magnocellular and parvocellular OT and AVP systems. In Neuroendocrinology, ed. Lightman SL & Everitt BJ, pp. 154-176. Blackwell, Oxford.
52. Robinson ICAF, Woolf CN & Parsons JA (1981). Suckling in the guinea-pig: the simultaneous release of oxytocin and neurophysin. J Endocrinol 90, 227-236.
53. Rocha e Silva M & Rosenberg M (1969). The release of vasopressin in response to haemorrhage and its role in the mechanism of blood pressure regulation. J Physiol 202, 535-557.
54. Russell JA & Leng G (2000). Veni, vidi, vici: the neurohypophysis in the twentieth century. Exp Physiol 85S, 1S-6S.
55. Swanson LW, Simmons DM, Arriza J, Hammer R, Brinster R, Rosenfeld M & Evans RM (1985). Novel developmental specificity in the nervous system of transgenic animals expressing growth hormone fusion genes. Nature 317, 363-366.
56. Terrier C, Chabot JG, Pautrat G, Jeandel L, Gray D, Lutz-Bucher B, Zingg HH & Morel G (1991). Arginine-vasopressin in anterior pituitary cells: in situ hybridization of mRNA and ultrastructural localization of immunoreactivity. Neuroendocrinology 54, 303-311.
57. Tominaga K, Shinohara K, Otori Y, Fukuhara C & Inouye ST (1992). Circadian rhythms of vasopressin content in the suprachiasmatic nucleus of the rat. Neuroreport 3, 809-812.
58. Vandesande P & Dierickx D (1975). Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretory system of the rat. Cell Tiss Res 164, 153-162.
59. Vandesande F, Dierickx K & De Mey J (1977). The origin of the vasopressinergic and oxytocinergic fibres of the external region of the median eminence of the rat hypophysis. Cell Tiss Res 180, 443-452.
60. Wahl GM, Lewis KA, Ruiz JC, Rothenberg B, Zhao J & Evans GA (1987). Cosmid vectors for rapid genomic walking, restriction mapping, and gene transfer. Proc Natl Acad Sci U S A 84, 2160-2164.
61. Waller S, Fairhall KM, Xu J, Robinson ICAF & Murphy D (1996). Neurohypophyseal and fluid homeostasis in transgenic rats expressing a tagged rat vasopressin prepropeptide in hypothalamic neurons. Endocrinology 137, 5068-5077.
62. Waller SJ & Murphy D (1995). Expression of rat vasopressin transgene in rats. In Recent Progress of Vasopressin and Oxytocin Research, ed. Saito T, Kurokawa K & Yoshida S, pp. 89-98. Elsevier Science BV, Amsterdam.
63. Waller SJ, Ratty A, Burbach JPH & Murphy D (1998). Transgenic and transcriptional studies on neurosecretory cell gene expression. Cell Mol Neurobiol 18, 149-171.
64. Wantanabe K, Vanecek J & Yamaoka S (2000). In vitro entrainment of the circadian rhythm of vasopressin-releasing cells in the suprachiasmatic nucleus by vasoactive intestinal polypeptide. Brain Res 877, 361-366.
65. Wells T, Flavell DM, Wells SE, Carmignac DF & Robinson ICAF (1997). Effects of growth hormone secretagogues in the transgenic growth-retarded (Tgr) rat. Endocrinology 138, 580-587.
66. Winslow JT, Hastings N, Carter CS, Harbaugh CR & Insel TR (1993). A role for central vasopressin in pair bonding in monogamous prairie voles. Nature 365, 545-548.
67. Young III WS, Iacangelo A, Luo X-Z, King C, Duncan K & Ginns EI (1999). Transgenic expression of green fluorescent protein in mouse oxytocin neurones. J Neuroendocrinol 11, 935-939.
68. Young III WS, Reynolds K, Shepard EA, Gainer H & Castel M (1990). Cell-specific expression of the rat oxytocin gene in transgenic mice. J Neuroendocrinol 2, 917-925.
69. Zeng Q, Carter DD & Murphy D (1994). Cell specific expression of a vasopressin transgene in rats. J Neuroendocrinol 6, 469-477.
70. Zhang BJ, Kusano K, Zerfas P, Iacangelo A, Young WS & Gainer H (2002). Targeting of green fluorescent protein to secretory granules in oxytocin magnocellular neurones and its secretion from neurohypophysial nerve terminals in transgenic mice. Endocrinology 143, 1036-1046.